{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "PI3KamTOR_Inhibitor_PKI-179",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A second generation, small-molecule mimetic of ATP that targets the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. PKI-179 selectively inhibits mTOR and phosphoinositide-3-kinase (PI3K) alpha. By inhibiting the PI3K/mTOR signaling pathway, this agent may inhibit tumor cell proliferation and survival.",
    "fdaUniiCode": "CNN7Y60164",
    "identifier": "C90291",
    "preferredName": "PI3Ka/mTOR Inhibitor PKI-179",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C129825",
      "C2152"
    ],
    "synonyms": [
      "PI3Ka/mTOR Inhibitor PKI-179",
      "PKI-179"
    ]
  }
}